|
|
|
 |
|
As a prerequisite for high-quality biomedical research and key resource for translational research, biobanks can provide a critical competitive advantage for the advancement of biotechnology, human health and disease related activities if they are well collected, characterized and accessible. China has a large patient population, and an increasing number of biobanks have been set up, however, the diversity, lack of standardisation, different rules of access of these biobanks and the different ethical and legal landscape across China has prevented their effective use.
With the theme of “Biobank management and Quality Control”, the conference will explore the latest development, share best practice and feature first-hand experience in the management, quality control, ethical issues related to biobank development with senior professionals, top academics and leaders from global biobank projects and institutes such as BBMRI, French National Institutes of Health (INSERM), UK Biobank, etc., as well as domestic leading hospitals, institutions and pharmaceutical companies.
Read more... |
|
| |
 |
 |
Kurt Zatloukal, M.D.
Coordinator of ESFRI Biomedical and Biobanking Resources Research Infrastructure (BBMRI)
Professor of Pathology, Institute of Pathology, Medical University of Graz |
 |
Bruno Clément, Ph.D.
Head of the Inserm Unit "Liver, Metabolisms and Cancer"
Chairman of the National Committee for Biological Resources in the Ministry of Research
CSO of the Biobank National Infrastructure |
| |
 |
Paul Downey, MBA
Director of Operations, UK Biobank |
 |
Georges Dagher, Ph.D.
Deputy Director, Clinical Research Dpt, INSERM, Paris
Leader of Funding & Financing at BBMRI
Director of clinical research infrastructures and the coordinator of the French network of biobanks |
| |
 |
Paul Hofman, MD, Ph.D.
Head of the Laboratory of Clinical and Experimental Pathology, Pasteur Hospital
Head of the Human Biobank Unit, Pasteur Hospital
Head of the ERI-21/EA 4319, INSERM, France |
 |
Christian DEMANZE
Manager of consulting office ISO.L.A
Lead auditor and teacher QSE SGS-ICS |
| |
 |
Christian C. Oste, Ph.D.
President of Bioscope International, LLC, Spain
Member, International Society for Biological and Environmental Repositories (ISBER)
Member, Public Population Project in Genomics (P3G) |
 |
Daniel Groelz, Ph.D.
Scientific Associate Director R&D, QIAGEN GmbH
Member of SPIDIA project (FP7) |
| |
 |
Vera Holländer, Ph.D.
Senior Scientist R&D, QIAGEN GmbH |
 |
Carola Schade, Ph.D.
Business Director Automation, QIAGEN GmbH |
| |
 |
Ms. Angelien Heister
BaSc
Supervisor, Radboud Biobank
Researcher, Department of Human Genetics, Radboud University Nijmegen Medical Centre |
 |
Rongxing Gan, Professor MBA
President & CEO, Shanghai Clinical Research Center |
| |
 |
Jiayou Chu, Ph.D.
Professor of Chinese Academy of Medical Sciences, Medical Biology Institute of Beijing Union Medical College
Project Director of Studies of the Preservation of Genome of Different Ethnic Groups in China and immortal bio-bank of different ethnic groups in China within the human genome project |
 |
Youyong Lv, Ph.D.
Professor of the college of clinical oncology, Beijing University, researcher of Beijing Institute of Cancer Prevention and Treatment, Doctoral tutor and Director of Beijing Molecular Oncology Laboratory. |
| |
 |
Shilin Li, Ph.D.
Associate Research Professor,
MOE Key Laboratory of
Contemporary Anthropology at Fudan University |
 |
Yong Zhang, Ph.D.
Head of Proteomics Division at BGI Shenzhen
Project Director at BGI Shenzhen |
|
|
